Personalized Medicine, Pharma Leadership, and the Human Side of Drug Development with Guest Dr. David Krause

From developing early childhood vaccines to advancing neuropsychiatric treatments and personalized oncology, Bracken Senior Partner Dr. David Krause has spent more than three decades at the forefront of clinical development and medical affairs. 

A board-certified physician and former CMO with deep experience across global pharma and startup biotech, David brings both scientific depth and a patient-first mindset to every stage of drug development. 

In this episode of Fractals: Life Science Conversations, David joins host Colin Miller to discuss: 

• The role of mentorship in shaping leadership—and why hiring your successor is a smart long game
• How personalized medicine, pharmacogenomics, and psychedelics are changing the treatment landscape in CNS
• What the FDA gets right (and wrong) about innovation—and how the industry can engage more effectively 
• Lessons from vaccine development and gene therapy—and where David would place his next $100M investment.

Listen to Fractals on your favorite podcast platform, and contact Bracken to learn how our cross-functional teams can support your clinical, medical, and regulatory strategy. 

Click here to read the transcript version of this episode.